Should MRD Guide Myeloma Treatment? A Debate. | Rahul Banerjee, MD and Sridevi Rajeeve, MD |IMS 2024
Debate on MRD decision making between Dr. Rahul Bannerjee and Dr. Sridevi Rajeeve, recorded on September 28, 2024 at the IMS annual meeting in Rio de Janeiro. The HealthTree Foundation for Multiple Myeloma brings information from the experts to the patients! Learn more at https://www.healthtree.org/myeloma/co... Donate to the HealthTree Foundation for Multiple Myeloma or learn more about additional myeloma support we offer here: https://give.healthtree.org/campaign/... HealthTree Cure Hub helps you find your best treatment options and accelerate a cure for multiple myeloma. Join today at https://www.healthtree.org/ Follow HealthTree: twitter.com/healthtreeformm facebook.com/healthtreeformultiplemyeloma instragram.com/healthtreeformultiplemyeloma

Newly Diagnosed Multiple Myeloma (NDMM) Breakout Session | Sridevi Rajeeve, MD | Tampa RT

Expert Cancer Panel: Multiple myeloma with high-risk cytogenetics and extramedullary involvement

Top Myeloma Research Presented at ASCO & EHA 2024

Can You Stop Myeloma Treatment and Still Stay in Remission?

Dietary Guidelines for Blood Cancer Patients After Treatment

Your Multiple Myeloma Lab Results, Decoded: What They Mean and What They Don’t

Managing Side Effects of MGUS/Smoldering Myeloma Patients

Myeloma and Dexamethasone: Insights on Tapering, Dose Intensity, and Eye Health from New Research

FAQs: Understanding High-Risk Multiple Myeloma: Beyond Genetics and Key Considerations

Myeloma 101: Understanding Multiple Myeloma, Risk Factors, Diagnosis & Treatments Explained

Exciting Clinical Trials for CLL in 2025

Know Your Myeloma Immunotherapy: Teclistamab and other Bispecifics

Understanding Pre-Myeloma (MGUS)

A Day in the Life of Myeloma Patient Adrienne and Care Partner Chad Moore

How Does Inflammation Relate to Cancer?

FAQs: Immunotherapy for Multiple Myeloma: Exploring Options Through Your Disease Journey

Patient & Family Seminar 2024 | Advancements in Myeloma Treatment Strategies: Multiple Drugs Upfront

Updates in Multiple Myeloma in 2024: From Bench to Bedside

Smoldering Myeloma: What We Know and Where We're Going

